CRL
Charles River Laboratories International, Inc.
Platform & Compounding FCF
C-
45.8 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
6.8%
-
Operating Margin Trend
-1.88 pp/yr
-
5yr Avg ROE
7.7%
-
5yr Share-Count CAGR
-0.9%
-
5yr Revenue CAGR
3.2%
-
5yr EPS CAGR
-70.3%
-
Revenue-Growth Years (5)
3/5
-
5yr FCF Margin
11.3%
-
5yr FCF/NI Conversion
12.86x
-
Net Debt / EBITDA
3.13x
-
Interest Coverage (EBIT/Int)
4.74x
-
Altman Z-Score
2.00
Stability
Weight: 5%
D
39
-
EPS Volatility (σ/μ)
0.59
-
Piotroski F-Score
4
-
Negative-Revenue Years (5)
2/5
3 of 5 gurus held; 1 added; 2 trimmed; 2 full exits.
- Holders
- 3
-2
- Avg Δ position
-
-33.4%
- New buys
- 0
- Full exits
- 2